Predictive Technology Group, Inc.

Equities

PRED

US74039H1023

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 01:15:13 2024-04-19 pm EDT			5-day change	1st Jan Change
0.0005 ^USD	0.00%		0.00%	+66.67%

Jan. 12	Motion For Case Conversion Approved for Predictive Technology Group, Inc.	CI
2023	Motion for Case Conversion Filed by Predictive Technology Group, Inc.	CI

Global Enterprises Group, Inc Reports Earnings Results for the Full Year Ended June 30, 2019

September 30, 2019 at 04:04 pm EDT

Global Enterprises Group, Inc. announced earnings results for the full year ended June 30, 2019. For the full year, the company announced sales was USD 43.493 million compared to USD 16.624 million a year ago. Operating loss was USD 19.940 million compared to USD 12.325 million a year ago. Net loss was USD 15.305 million compared to USD 6.067 million a year ago. Basic loss per share was USD 0.06 compared to USD 0.03 a year ago.

Latest news about Predictive Technology Group, Inc.

Motion For Case Conversion Approved for Predictive Technology Group, Inc.	Jan. 11	CI
Motion for Case Conversion Filed by Predictive Technology Group, Inc.	Dec. 13	CI
Subchapter V Trustee Appointed Under Chapter 11 for Predictive Technology Group, Inc.	Nov. 14	CI
Predictive Technology Group, Inc. Filed for Bankruptcy	Nov. 09	CI
Predictive Technology Group, Inc. Announces Resignation of Jacob Easdale as Chief Accounting Officer	21-10-07	CI
Predictive Technology Group, Inc. Announces Chief Financial Officer Changes	21-10-07	CI
Predictive Technology Group, Inc. Announces Executive Changes	21-08-11	CI
Predictive Technology Group, Inc. Entered into Strategic Development Agreement with Nebula Genomics	21-06-21	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021	21-05-17	CI
Predictive Technology Group, Inc. Announces Executive Changes	21-02-17	CI
Predictive Technology Group, Inc. Announces Executive Changes	21-02-17	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020	21-02-16	CI
Predictive Technology Group, Inc. Enters into an Amendment and Termination Agreement with ProPhase	21-01-19	CI
Predictive Technology Group, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020	20-11-16	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Full Year Ended June 30, 2020	20-10-20	CI
Predictive Technology Group, Inc. Auditor Raises 'Going Concern' Doubt	20-10-19	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2020	20-05-15	CI
Predictive Technology Group Announces Initial Order of One Million Units of the Assurance AB™ COVID-19 IgM/IgG Rapid Antibody Test from Distribution Partner, Wellgistics, LLC	20-04-08	CI
Predictive Technology Group and Jiangsu Dablood Pharmaceutical Co, Ltd. Provide Updates of its Assurance AB COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care	20-03-30	CI
Predictive Technology Group Announces Launch of Assurance AB COVID-19 IgM/IgG Rapid Antibody Test for Use by Laboratories and Healthcare Workers at the Point of Care	20-03-25	CI
Predictive Technology Group, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2019	20-02-14	CI
Predictive Technology Group and Atrin Pharmaceuticals Announce Molecular Diagnostic Oncology Development Collaboration	20-01-28	CI
Jay Moyes Resigns as a Director of the Predictive Technology Group, Inc	20-01-07	CI
Predictive Technology Group, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2019	19-11-14	CI
Global Enterprises Group, Inc Reports Earnings Results for the Full Year Ended June 30, 2019	19-09-30	CI

Chart Predictive Technology Group, Inc.

Duration

Period

More charts

Company Profile

Predictive Technology Group, Inc. is a life science company. The Company, through its subsidiaries, is focused on specific points of the care continuum, including detection, prevention and treatment. Predictive Analytics, Predictive Laboratories, and Predictive Biotech each bring critical solutions to personalized patient care by leveraging its research, genomics, genetic library and expertise in developing bioscience solutions. Predictive Analytics is the repository for its genetic library. Predictive Biotech provides regenerative medicine. Its products are derived from tissue sources rich in properties that support the bodyâs natural ability to heal itself. All products are safely, ethically and minimally processed to deliver allografts that preserve the naturally occurring characteristics and factors of the donor tissue. Its research and use of processing methods has propelled its placental-derived and Whartonâs Jelly umbilical cord-derived products to new heights.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
PREDICTIVE TECHNOLOGY GROUP, INC.	+66.67%	158K
IQVIA HOLDINGS INC.	+1.51%	42.75B
LONZA GROUP AG	+49.22%	41.61B
MODERNA, INC.	+8.57%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research